Sandoz has entered into an agreement to acquire the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Ltd. The acquisition consists of shares in Aspen Japan K.K. and associated assets held by AGI. Under the agreement, Sandoz will pay an initial cash consideration of €300 million, and a certain deferred consideration of up to €100 million.
Aspen's Generic Hydroxyprogesterone Caproate Receives Approval In US
JOHANNESBURG (Reuters) - Aspen Pharmacare has struck a deal with U.S. generics maker Mylan to distribute a portfolio of prescription and over-the-counter drugs in Australia and New Zealand.
Aspen Pharmacare has seen some financial weakness lately, but that hasn’t stopped it from pledging to make its largest manufacturing investment ever. The South African drugmaker says it will invest nearly $235 million in a facility to manufacture sterile anesthetics.
Mivacurium: List of nationally authorised medicinal products
Pancreatic cell transplants have the potential to be a permanent treatment for Type 1 diabetes. Problem is, the cells have trouble forming the blood vessel networks they need to thrive and provide insulin to patients. So scientists in the U.S. and Japan devised a new tissue engineering method to tackle this blood-supply problem in pancreatic cell transplantation. Using the method, they created pancreatic islets that cured severe Type 1 diabetes when they were transplanted into mice.
Aspen Moves Production to New $79 Million South Africa Plant
Aspen Pharmacare Holdings Ltd. sees China eventually overtaking South Africa as its biggest market as the company completes its transition to a global therapeutics business from an Africa-focused generic-drugs maker.
Johannesburg – The Competition Commission has decided to drop its investigation into Aspen Pharmacare [JSE:APN] over excessive pricing of cancer medicines.